Cytek BioSciences 

€4.1
28
+€0.04+0.99% Today

Statistics

Day High
4.1
Day Low
4.06
52W High
5.45
52W Low
2.14
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
-0.29
-0.2
-0.11
-0.02
Expected EPS
-0.078938575
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8EQ.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biodesix
BDSX
Mkt Cap111.99M
Biodesix is a competitor because it also operates in the biotechnology sector focusing on diagnostic solutions, similar to Cytek's focus on cell analysis technologies.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health operates in the precision oncology field, offering liquid biopsies and cancer diagnostics that compete with Cytek's diagnostic solutions.
Illumina
ILMN
Mkt Cap20.63B
Illumina, Inc. competes with Cytek through its next-generation sequencing (NGS) technologies, which are used in genetic analysis and overlap with Cytek's cell analysis market.
Pacific Biosciences of California
PACB
Mkt Cap496.78M
Pacific Biosciences of California offers long-read sequencing technologies, competing in the broader genomics and cell analysis market that Cytek targets.
Qiagen NV
QGEN
Mkt Cap7.06B
QIAGEN N.V. provides sample and assay technologies for molecular diagnostics, competing with Cytek in the life sciences and molecular diagnostics sectors.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific offers a wide range of analytical instruments and reagents, including those for cell analysis, directly competing with Cytek's product offerings.
Danaher
DHR
Mkt Cap123.97B
Danaher Corporation, through its Life Sciences segment, offers products and services that compete with Cytek's cell analysis and cytometry solutions.
Agilon Health
AGL
Mkt Cap492.8M
Agilent Technologies provides instruments, services, and consumables for laboratories, including cell analysis technologies that compete with Cytek BioSciences.

About

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Show more...
CEO
Dr. Wenbin Jiang Ph.D.
Employees
702
Country
United States
ISIN
US23285D1090

Listings

0 Comments

Share your thoughts

FAQ

What is Cytek BioSciences stock price today?
The current price of 8EQ.STU is €4.1 EUR — it has increased by +0.99% in the past 24 hours. Watch Cytek BioSciences stock price performance more closely on the chart.
What is Cytek BioSciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cytek BioSciences stocks are traded under the ticker 8EQ.STU.
Is Cytek BioSciences stock price growing?
8EQ.STU stock has risen by +7.41% compared to the previous week, the month change is a +4.1% rise, over the last year Cytek BioSciences has showed a +26.09% increase.
When is the next Cytek BioSciences earnings date?
Cytek BioSciences is going to release the next earnings report on May 07, 2026.
What were Cytek BioSciences earnings last quarter?
8EQ.STU earnings for the last quarter are -0.29 EUR per share, whereas the estimation was -0.02 EUR resulting in a -1,600% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Cytek BioSciences have?
As of May 06, 2026, the company has 702 employees.
In which sector is Cytek BioSciences located?
Cytek BioSciences operates in the Health & Wellness sector.
When did Cytek BioSciences complete a stock split?
Cytek BioSciences has not had any recent stock splits.
Where is Cytek BioSciences headquartered?
Cytek BioSciences is headquartered in Fremont, United States.